Camp4 Therapeutics (CAMP) Income from Continuing Operations (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Income from Continuing Operations of 12217000.0 for Q1 2026, up 10.49% on a YoY basis from 11057604.35 in Q1 2025, and up 5.6% sequentially from 12942000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Income from Continuing Operations data on file, last reported at 12217000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 10.49% year-over-year to 12217000.0; the trailing twelve-month figure through Mar 2026 stood at 59392000.0 (up 8.34% YoY), and the FY2025 full-year result was 126521000.0, down 8.44% from the prior year.
- Income from Continuing Operations grew to 12217000.0 in Q1 2026, from 12942000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 12217000.0 in Q1 2026 to a low of 23775000.0 in Q3 2024.
- A 4-year average of 14867727.27 and a median of 13583000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations plunged 91.67% in 2024 and soared 40.68% in 2025, its largest moves.
- Tracing CAMP's Income from Continuing Operations over 4 years: stood at 13371000.0 in 2023, then retreated by 6.88% to 14291000.0 in 2024, then climbed by 9.44% to 12942000.0 in 2025, then climbed by 5.6% to 12217000.0 in 2026.
- Business Quant data shows CAMP's Income from Continuing Operations at 12217000.0 in Q1 2026, 12942000.0 in Q4 2025, and 14104000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | Camp4 Therapeutics | 195.78 Mn | 195.78 Mn | - | -12.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.22 Mn |
| Dec 31, 2025 | -12.94 Mn |
| Sep 30, 2025 | -14.10 Mn |
| Jun 30, 2025 | -20.13 Mn |
| Mar 31, 2025 | -13.65 Mn |
| Dec 31, 2024 | -14.29 Mn |
| Sep 30, 2024 | -23.78 Mn |
| Jun 30, 2024 | -13.08 Mn |
| Mar 31, 2024 | -13.58 Mn |
| Dec 31, 2023 | -13.37 Mn |
| Sep 30, 2023 | -12.40 Mn |